The Increased Expression of Matrix Metalloproteinase-9 Messenger RNA in the Non-lesional Skin of Patients with Large Plaque Psoriasis Vulgaris

키워드

참고문헌 (44)

1. Lowes MA, "Pathogenesis and therapy of psoriasis", Nature, 445, pp.866~873 (2007)
2. Austin LM, "The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1(cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients", J Invest Dermatol, 113, pp.752~759 (1999)
3. Jariwala SP, "The role of dendritic cells in the immunopathogenesis of psoriasis", Arch Dermatol Res, 299, pp.359~366 (2007)
4. Terui T, "Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammationboosting loop", Exp Dermatol, 9, pp.1~10 (2000)
5. Nickoloff BJ, "Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis", J Investig Dermatol Symp Proc, 통권 : 5, pp.67~73 (2000)
6. Bowcock AM, "Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies", Hum Mol Genet, 10, pp.1793~1805 (2001)
7. Rottman JB, "Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris", Lab Invest, 81, pp.335~347 (2001)
8. Lew W, "Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression", Trends Immunol, 25, pp.295~305 (2004)
9. Lew W, "Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque(Western) and small plaque (Asian) psoriasis vulgaris", Br J Dermatol, 150, pp.668~676 (2004)
10. Dinarello CA, "Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme", Ann N Y Acad Sci, 856, pp.1~11 (1998)
11. Abraham M, "The role of IL-18 and IL-12 in the modulation of matrix metalloproteinases and their tissue inhibitors in monocytic cells", Int Immunol, 14, pp.1449~1457 (2002)
12. Zhang B, "IL-18 increases invasiveness of HL-60 myeloid leukemia cells: up-regulation of matrix metalloproteinases-9 (MMP-9) expression", Leuk Res, 28, pp.91~95 (2004)
13. Tamai K, "Interferon-gamma coordinately upregulates matrix metalloprotease (MMP)-1 and MMP-3, but not tissue inhibitor of metalloproteases(TIMP), expression in cultured keratinocytes", J Invest Dermatol, 104, pp.384~390 (1995)
14. Hebenstreit D, "Signaling mechanisms, interaction partners, and target genes of STAT6", Cytokine Growth Factor Rev, 17, pp.173~188 (2006)
15. Kruse N, "Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood", J Immunol Methods, 210, pp.195~203 (1997)
16. Heid CA, "Real time quantitative PCR", Genome Res, 6, pp.986~994 (1996)
17. van Ruissen F, "Differential effects of detergents on keratinocyte gene expression", J Invest Dermatol, 110, pp.358~363 (1998)
18. Mauviel A, "Cytokine regulation of metalloproteinase gene expression", J Cell Biochem, 53, pp.288~295 (1993)
19. Saren P, "TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages", J Immunol, 157, pp.4159~4165 (1996)
20. Lavigne MC, "Human bronchial epithelial cells express and secrete MMP-12", Biochem Biophys Res Commun, 324, pp.534~546 (2004)
21. Wolk K, "IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis", Eur J Immunol, 36, pp.1309~1323 (2006)
22. Opdenakker G, "Gelatinase B: a tuner and amplifier of immune functions", Trends Immunol, 22, pp.571~579 (2001)
23. Fleischmajer R, "Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2", J Invest Dermatol, 115, pp.771~777 (2000)
24. Suomela S, "Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions", Exp Dermatol, 10, pp.175~183 (2001)
25. Thewes M, "Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase(MMP)-11 in benign and malignant skin tumours and other skin disorders", Clin Exp Dermatol, 24, pp.122~126 (1999)
26. Suomela S, "Matrix metalloproteinase-19 is expressed by keratinocytes in psoriasis", Acta Derm Venereol, 83, pp.108~114 (2003)
27. Nestle FO, "Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production", J Exp Med, 202, pp.135~143 (2005)
28. Nestle FO, "Defining upstream elements of psoriasis pathogenesis: an emerging role for interferon alpha", J Invest Dermatol, 125, pp.xiv~xv (2005)
29. Ninomiya T, "Significance of serum matrix metalloproteinases and their inhibitors on the antifibrogenetic effect of interferon- alfa in chronic hepatitis C patients", Intervirology, 44, pp.227~231 (2001)
30. Flisiak I, "Effect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scales", Acta Derm Venereol, 86, pp.17~21 (2006)
31. Flisiak I, "Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1", J Eur Acad Dermatol Venereol, 19, pp.418~421 (2005)
32. Feliciani C, "The 72-kDa and the 92-kDa gelatinases, but not their inhibitors TIMP-1 and TIMP-2, are expressed in early psoriatic lesions", Exp Dermatol, 6, pp.321~327 (1997)
33. Nickoloff BJ, "Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis", Am J Pathol, 138, pp.129~140 (1991)
34. Ettehadi P, "Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions", Clin Exp Immunol, 96, pp.146~151 (1994)
35. Uyemura K, "The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cellmediated response", J Invest Dermatol, 101, pp.701~705 (1993)
36. Schlaak JF, "T cells involved in psoriasis vulgaris belong to the Th1 subset", J Invest Dermatol, 102, pp.145~149 (1994)
37. Nickoloff BJ, "Role of interferon-gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events", Arch Dermatol, 124, pp.1835~1843 (1988)
38. Szabo SK, "Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4＋ and CD8＋ subsets", J Invest Dermatol, 111, pp.1072~1078 (1998)
39. Giannelli G, "Altered expression of basement membrane proteins and their integrin receptors in lichen planus: possible pathogenetic role of gelatinases A and B", Lab Invest, 74, pp.1091~1104 (1996)
40. Niimi Y, "Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid", Int Arch Allergy Immunol, 139, pp.104~113 (2006)
41. Cordiali-Fei P, "Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha", J Autoimmune Dis, 3, pp.5~ (2006)
42. Cordiali-Fei P, "Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions", Ann N Y Acad Sci, 1110, pp.578~589 (2007)
43. Papathoma AS, "Role of matrix metalloproteinase-9 in progression of mouse skin carcinogenesis", Mol Carcinog, 31, pp.74~82 (2001)
44. Itoh T, "Experimental metastasis is suppressed in MMP-9-deficient mice", Clin Exp Metastasis, 17, pp.177~181 (1999)

관련 논문AI추천